Literature DB >> 29596697

Survival of patients with prior anti-angiogenic therapy.

Jens Eickhoff1,2, H Ian Robins2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29596697      PMCID： PMC5961420          DOI： 10.1093/neuonc/noy039

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  2 in total

Review 1.  Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature.

Authors:  Matthew Tipping; Jens Eickhoff; H Ian Robins
Journal:  J Clin Neurosci       Date:  2017-07-12       Impact factor: 1.961

2.  Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.

Authors:  Timothy F Cloughesy; Jan Drappatz; John de Groot; Michael D Prados; David A Reardon; David Schiff; Marc Chamberlain; Tom Mikkelsen; Annick Desjardins; Jerry Ping; Jaymes Holland; Ron Weitzman; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.